French
English
My Cerba
Our medical skills
Your reference laboratory, day after day
Histocytopathology
Specialized clinical pathology
Genetics and cytogenetics
About us
Your reference laboratory, day after day
Cerba
Cerba HealthCare
Innovation at Cerba
Quality support
Our commitments
Our services
Your reference laboratory, day after day
Sample collection
Order/prescribe a test
Your reference laboratory, day after day
Online catalog
Practical documents
Information
Your reference laboratory, day after day
Test focus
Medical topics
News
Newsletter archives
Contact us
Lab Cerba Home
Information
News
Arrêt du test de l’hydroxyproline urinaire
NEWS
26/05/23
Important notice : medium transport for NIPT
10/05/23
Anti-Platelet AC test - Stop
17/04/23
New Site Cerba Oncology
13/04/23
B6 VITAMIN : TECHNICAL CHANGE
12/04/23
NEW TEST : OPTICAL GENOME MAPPING
28/03/23
Midwives Days 2023
20/03/23
Next Cerba Live Session on Thursday 23 March: Analysis of human genomes by optical mapping
13/02/23
Lymphocytes T (T3/T4/T8) reagents
10/10/22
The Customer Relation Desk : Autumn opening hours
30/06/22
Customer service : summer holidays opening hours
20/05/22
Customer service : closed the 26th of May
14/04/22
Our Customer Service will be closed the 18th of April
18/03/22
NIPD, free circulating DNA tests - supplies back in stock
26/01/22
Best wishes !
05/07/21
IT Security Incident
11/05/21
New information on Myelogram bone marrow sampling
16/12/20
New: Cerba laboratory now proposes a range of tests for the diagnosis of lysosomal storage diseases.
28/10/20
Dépistage de la pré-éclampsie : de la clinique au laboratoire
22/06/20
New: recombinant peach allergen, rPru p 7 is now available
15/04/20
Change of technique and sample nature for Aldosterone measurement
27/11/19
Attention: new sampling recommendations and pre-analytical conditions for the total IgE in tears
17/09/19
Arrêt du test de l’hydroxyproline urinaire
11/01/19
Laboratoire CERBA enters into licensing agreement with IntegraGen for the commercialization of miR-31-3p tumor expression test in France, Benelux, Middle East and Africa
11/01/19
Laboratoire CERBA and PATHOQUEST announce partnership making the iDTECT™ BLOOD test available for clinical use in the precision diagnosis of infectious diseases
11/01/19
METAglut1, A NEW DIAGNOSTIC TEST FOR THE GLUT1 DEFICIENCY SYNDROME
11/01/19
Cerba HealthCare announces the launch of its endowment funds: « Institut Cerba »
11/01/19
Licensing agreement between Cerba and IntegraGen for the commercialization...
11/01/19
New blood test to diagnose cancers due to HPV.
All news
Arrêt du test de l’hydroxyproline urinaire
Arrêt du test de l’hydroxyproline urinaire